Drugs / DAPTACEL®
DAPTACEL®
Trials 6
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT00355121 | Oct 2006 → Jun 2009 | diphtheria, meningococcal meningitis, pertussis, poliomyelitis +1 | Sanofi | Completed | No outcome recorded |
| Phase 34 trials · 1 met primary | ||||||
| Phase 3 | NCT01346293 | Apr 2011 → May 2013 | diphtheria, measles, pertussis, poliomyelitis +1 | Sanofi Pasteur, a Sanofi Company | Completed | Met primary |
| Phase 3 | NCT00255047 | Nov 2005 → Jul 2008 | diphtheria, pertussis, poliomyelitis | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
| Phase 3 | NCT00258895 | Mar 2005 → Dec 2006 | diphtheria, pertussis, tetanus | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
| Phase 3 | NCT00662870 | May 2001 → Jan 2004 | diphtheria, haemophilus infectious disease, pertussis, poliomyelitis +1 | Sanofi | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT00802867 | Feb 2004 → Jun 2005 | diphtheria, haemophilus infectious disease, pertussis, poliomyelitis +1 | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01337167 Background | Apr 2011 → May 2013 | bacterial infectious disease, viral infectious disease | Merck Sharp & Dohme LLC | Completed | Mixed |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DAPTACEL | “The study was designed to compare the safety and immunogenicity of DTap-IPV with DAPTACEL® + IPOL® as the 5th dose booster” NCT01346293 ↗8“diphtheria, tetanus, 5-component acellular pertussis vaccine [DTaP(5); Daptacel]” PMID 19117896 ↗ Jan 2009 “Menactra® vaccine and DAPTACEL® vaccine” NCT00355121 ↗ “DAPTACEL®” NCT00662870 ↗ |
| Known as | Diphtheria and Tetanus Toxoids and Acellular Pertussis | “Diphtheria and Tetanus Toxoids and Acellular Pertussis (DAPTACEL®)” NCT00802867 ↗ |
| Known as | DTaP(5) | “diphtheria, tetanus, 5-component acellular pertussis vaccine [DTaP(5); Daptacel]” PMID 19117896 ↗ Jan 2009 |
| Modality | Vaccine | “DAPTACEL® vaccine” NCT00355121 ↗ |
| Route | Intramuscular | “0.5 mL, Intramuscular” NCT00258895 ↗ |